Literature DB >> 27312104

Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection.

Tyler A Rice1, Todd A Brenner1, Caroline M Percopo1, Michelle Ma1, Jesse D Keicher2, Joseph B Domachowske3, Helene F Rosenberg4.   

Abstract

Pattern recognition receptors (PRRs) engage microbial components in the lung, although their role in providing primary host defense against respiratory virus infection is not fully understood. We have previously shown that Gram-positive Lactobacillus plantarum (Lp) administered to the respiratory tract promotes full and sustained protection in response to an otherwise lethal mouse pneumovirus (PVM) infection, a robust example of heterologous immunity. While Lp engages PRRs TLR2 and NOD2 in ex vivo signaling assays, we found that Lp-mediated protection was unimpaired in single gene-deleted TLR2(-/-) and NOD2(-/-) mice. Here we demonstrate substantial loss of Lp-mediated protection in a double gene-deleted NOD2(-/-)TLR2(-/-) strain. Furthermore, we demonstrate protection against PVM infection by administration of the bi-functional NOD2-TLR2 agonist, CL-429. The bi-functional NOD2-TLR2 ligand CL-429 not only suppresses virus-induced inflammation, it is significantly more effective at preventing lethal infection than equivalent amounts of mono-molecular TLR2 and NOD2 agonists. Interestingly, and in contrast to biochemical NOD2 and/or TLR2 agonists, Lp remained capable of eliciting primary proinflammatory responses from NOD2(-/-)TLR2(-/-) mice in vivo and from alveolar macrophages challenged ex vivo. Taken together, we conclude that coordinate engagement of NOD2 and TLR2 constitutes a key step in the genesis of Lp-mediated protection from a lethal respiratory virus infection, and represents a critical target for modulation of virus-induced inflammatory pathology. Published by Elsevier B.V.

Entities:  

Keywords:  Cytokines; Inflammation; Pattern recognition receptors; Pneumovirus; Probiotic

Mesh:

Substances:

Year:  2016        PMID: 27312104      PMCID: PMC4980231          DOI: 10.1016/j.antiviral.2016.06.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  66 in total

Review 1.  Macrophage receptors implicated in the "adaptive" form of innate immunity.

Authors:  D M E Bowdish; M S Loffredo; S Mukhopadhyay; Alberto Mantovani; S Gordon
Journal:  Microbes Infect       Date:  2007-09-14       Impact factor: 2.700

2.  Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity.

Authors:  Vincent Pavot; Nicolas Rochereau; Julien Rességuier; Alice Gutjahr; Christian Genin; Gerard Tiraby; Eric Perouzel; Thierry Lioux; Fabienne Vernejoul; Bernard Verrier; Stéphane Paul
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 3.  Animal models of human respiratory syncytial virus disease.

Authors:  Reinout A Bem; Joseph B Domachowske; Helene F Rosenberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 4.  Chemotherapy of respiratory syncytial virus infections: the final breakthrough.

Authors:  Erik De Clercq
Journal:  Int J Antimicrob Agents       Date:  2015-02-02       Impact factor: 5.283

5.  Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.

Authors:  Katia E Garcia-Crespo; Calvin C Chan; Stanislaw J Gabryszewski; Caroline M Percopo; Peter Rigaux; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2012-12-26       Impact factor: 5.970

Review 6.  Host response to respiratory syncytial virus infection.

Authors:  Lourdes Arruvito; Silvina Raiden; Jorge Geffner
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

7.  MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx.

Authors:  Michael G Dorrington; Aoife M Roche; Sarah E Chauvin; Zhongyuan Tu; Karen L Mossman; Jeffrey N Weiser; Dawn M E Bowdish
Journal:  J Immunol       Date:  2012-11-28       Impact factor: 5.422

Review 8.  Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

9.  Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity.

Authors:  Min-Kyung Park; Vu Ngo; Young-Man Kwon; Young-Tae Lee; Sieun Yoo; Young-Hee Cho; Sung-Moon Hong; Hye Suk Hwang; Eun-Ju Ko; Yu-Jin Jung; Dae-Won Moon; Eun-Ji Jeong; Min-Chul Kim; Yu-Na Lee; Ji-Hun Jang; Joon-Suk Oh; Cheol-Hyun Kim; Sang-Moo Kang
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 10.  Alveolar macrophages: plasticity in a tissue-specific context.

Authors:  Tracy Hussell; Thomas J Bell
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

View more
  16 in total

1.  Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.

Authors:  Caroline M Percopo; Michelle Ma; Todd A Brenner; Julia O Krumholz; Timothy J Break; Karen Laky; Helene F Rosenberg
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

2.  Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1-/- mice.

Authors:  Caroline M Percopo; Michelle Ma; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2017-06-15       Impact factor: 4.962

3.  Silkworm larvae plasma (SLP) assay for detection of bacteria: False positives secondary to inflammation in vivo.

Authors:  Michelle Ma; Tyler A Rice; Caroline M Percopo; Helene F Rosenberg
Journal:  J Microbiol Methods       Date:  2016-11-10       Impact factor: 2.363

Review 4.  The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19.

Authors:  Bruno G N Andrade; Rafael R C Cuadrat; Fernanda Raya Tonetti; Haruki Kitazawa; Julio Villena
Journal:  Biosci Microbiota Food Health       Date:  2022-03-29

Review 5.  Antiviral Effects and Underlying Mechanisms of Probiotics as Promising Antivirals.

Authors:  Yanjin Wang; Assad Moon; Jingshan Huang; Yuan Sun; Hua-Ji Qiu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

6.  Persistent Airway Hyperresponsiveness Following Recovery from Infection with Pneumonia Virus of Mice.

Authors:  Ajinkya R Limkar; Caroline M Percopo; Jamie L Redes; Kirk M Druey; Helene F Rosenberg
Journal:  Viruses       Date:  2021-04-22       Impact factor: 5.048

7.  Innate immune memory through TLR2 and NOD2 contributes to the control of Leptospira interrogans infection.

Authors:  Ignacio Santecchia; Frédérique Vernel-Pauillac; Orhan Rasid; Jessica Quintin; Maria Gomes-Solecki; Ivo G Boneca; Catherine Werts
Journal:  PLoS Pathog       Date:  2019-05-20       Impact factor: 6.823

Review 8.  The microbiota of the respiratory tract: gatekeeper to respiratory health.

Authors:  Wing Ho Man; Wouter A A de Steenhuijsen Piters; Debby Bogaert
Journal:  Nat Rev Microbiol       Date:  2017-03-20       Impact factor: 60.633

9.  Alternaria alternata Accelerates Loss of Alveolar Macrophages and Promotes Lethal Influenza A Infection.

Authors:  Caroline M Percopo; Michelle Ma; Eric Mai; Jamie L Redes; Laura S Kraemer; Mahnaz Minai; Ian N Moore; Kirk M Druey; Helene F Rosenberg
Journal:  Viruses       Date:  2020-08-27       Impact factor: 5.048

Review 10.  Phagocyte Escape of Leptospira: The Role of TLRs and NLRs.

Authors:  Ignacio Santecchia; María Florencia Ferrer; Monica Larucci Vieira; Ricardo Martín Gómez; Catherine Werts
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.